These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8448541)

  • 41. Unrelated allogeneic bone marrow donation: short- and long-term follow-up of 103 consecutive volunteer donors.
    Gandini A; Roata C; Franchini M; Agostini E; Guizzardi E; Pontiero Giacometti P; Vassanelli A; Rocca P; Zanuso C; Fasolo R; de Gironcoli M; Gandini G; Benedetti F; Aprili G;
    Bone Marrow Transplant; 2001 Aug; 28(4):369-74. PubMed ID: 11571509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia.
    Chiang KY; Van Rhee F; Godder K; Bridges K; Adams S; Mehta J; Henslee-Downey PJ
    Bone Marrow Transplant; 2001 Mar; 27(5):507-10. PubMed ID: 11313684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allogeneic bone marrow transplantation for chronic myeloid leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S7-9. PubMed ID: 8769691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors.
    Demuynck H; Verhoef GE; Zachee P; Emonds MP; van der Schueren E; van den Berghe H; Vandenberghe P; Casteels-Van Daele M; Boogaerts MA
    Bone Marrow Transplant; 1996 May; 17(5):745-51. PubMed ID: 8733692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chromosomal transformation in donor cells following allogeneic bone marrow transplantation.
    Lang Z; Dinndorf P; Ladisch S; Bayever E; Reaman G
    Bone Marrow Transplant; 2004 Jun; 33(12):1253-6. PubMed ID: 15146169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
    Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
    Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allogeneic bone marrow transplantation using unrelated donors.
    Champlin R
    Leuk Lymphoma; 1993; 11 Suppl 2():149-52. PubMed ID: 8124226
    [No Abstract]   [Full Text] [Related]  

  • 48. Bone marrow transplantation from unrelated volunteer donors. An overview.
    Busca A; Amoroso A; Miniero R
    Panminerva Med; 1997 Jun; 39(2):71-7. PubMed ID: 9230614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Donor leukocyte infusion for relapsed ANLL after allogeneic BMT and the use of interferon alpha to induce graft-versus-leukemia effect.
    Gürman G; Arslan O; Koç H; Akan H
    Bone Marrow Transplant; 1996 Oct; 18(4):825-6. PubMed ID: 8899208
    [No Abstract]   [Full Text] [Related]  

  • 50. A new method of bone marrow transplantation leads to extension of skin allograft survival.
    Siemionow M; Ozer K; Izycki D; Unsal M; Klimczak A
    Transplant Proc; 2005 Jun; 37(5):2309-14. PubMed ID: 15964406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donors.
    Ordemann R; Hölig K; Wagner K; Rautenberg U; Bornhäuser M; Kroschinsky F; Schäfer J; Schuler U; Ehninger G
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S25-8. PubMed ID: 9712488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunodeficiency after allogeneic bone marrow transplantation in man: the role of antigen presenting cells.
    Møller J; Dickmeiss E; Jacobsen N; Svejgaard A
    Tokai J Exp Clin Med; 1996 Feb; 21(1):13-7. PubMed ID: 9239799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent advances in allogeneic hematopoietic stem-cell transplantation.
    Devine SM; Adkins DR; Khoury H; Brown RA; Vij R; Blum W; DiPersio JF
    J Lab Clin Med; 2003 Jan; 141(1):7-32. PubMed ID: 12518165
    [No Abstract]   [Full Text] [Related]  

  • 55. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings].
    Morimoto T; Hattori K; Yabe H; Yabe M; Hinohara T; Shimizu T; Matsumoto M; Hagihara M; Tsuji K; Kato S
    Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bone marrow transplantation moves from the XXth to the XXIth century].
    Jouet JP
    Med Sci (Paris); 2010 May; 26(5):447-8. PubMed ID: 20510134
    [No Abstract]   [Full Text] [Related]  

  • 57. Allogeneic bone marrow transplantation: problems and prospects.
    Armitage JO
    Mayo Clin Proc; 1992 Feb; 67(2):195-7. PubMed ID: 1545582
    [No Abstract]   [Full Text] [Related]  

  • 58. [Forming a list of volunteers for bone marrow donation].
    Raffoux C; Hervé P
    Soins; 1989; (526-527):23-5. PubMed ID: 2814604
    [No Abstract]   [Full Text] [Related]  

  • 59. Bone marrow transplantation.
    Beutler E
    West J Med; 1989 Dec; 151(6):658-9. PubMed ID: 2487998
    [No Abstract]   [Full Text] [Related]  

  • 60. Critical situation of bone marrow transplantation: information distribution regarding the problem of a shortage of bone marrow filters.
    Narimatsu H; Takita M; Kodama Y; Horigome K; Kishi Y; Kusumi E; Hamaki T; Matsumura T; Tanaka Y; Kami M
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):141-2. PubMed ID: 19772945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.